Thomson CompuMark, a leader in trademark searching and brand protection solutions and part of Thomson Reuters,announced the launch of Global Pharmaceutical Search, a new service providing global trademark intelligence in an online report.
Avoiding potential confusion among pharmaceutical brands, which can sometimes lead to prescription errors, is a critically important public health concern. To address this, regulatory bodies in the United States and Europe have implemented rigorous processes for evaluating and approving pharmaceutical brand names. Searching globally for confusingly similar trademarks early in the process is important to minimize the chance of name rejection, which can be a costly misstep for pharmaceutical companies.
New Global Pharmaceutical Search addresses this critical need. It leverages Thomson CompuMark’s industry-leading global trademark content—including common law and web content—to give brand owners comprehensive yet concise information on trademark availability from key pharmaceutical markets, all in a single report.
Search coverage includes Thomson CompuMark’s proprietary, quality-checked trademark office records, web and domain name coverage, and U.S. and European regulatory and industry-specific sources, including pharmaceutical names in use. Brand owners can select the registers that match their product strategy, including the U.S., U.K., Spain, France, Germany, Switzerland, Italy, Benelux, and Canada.
Designed to save users valuable time, Global Pharmaceutical Search results are delivered online and also include access to the analysis tool on SERION. This easy-to-use online analysis tool enables users to rapidly pinpoint potential conflicts, perform follow-up research on marks of interest with a single click, and create and share custom reports on their findings in seconds.